Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S R Friedman

Showing results (131-140 of 146) with videos related to

Pageof 15
Sort By:
The American Journal of Drug and Alcohol Abuse|December 1, 2001
Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto RicoJ F Andía, S Deren, S Y Kang, et al.
AIDS (London, England)|May 1, 1987
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York CityM Marmor, D C Des Jarlais, H Cohen, et al.
Science (New York, N.Y.)|November 11, 1988
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York CityR L Stoneburner, D C Des Jarlais, D Benezra, et al.
AIDS (London, England)|July 1, 1987
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug usersD C Des Jarlais, S R Friedman, M Marmor, et al.
American Journal of Public Health|March 8, 2000
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemicD C Des Jarlais, M Marmor, P Friedmann, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
American Journal of Public Health|February 24, 2001
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York CityT Diaz, D C Des Jarlais, D Vlahov, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Current HIV/AIDS Reports|June 23, 2018
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV PreventionPedro Mateu-Gelabert, H Guarino, K Quinn, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
Pageof 15

Showing results (131-140 of 146) with videos related to

Sort By:
Pageof 15
The American Journal of Drug and Alcohol Abuse|December 1, 2001
Residential status and HIV risk behaviors among Puerto Rican drug injectors in New York and Puerto RicoJ F Andía, S Deren, S Y Kang, et al.
AIDS (London, England)|May 1, 1987
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York CityM Marmor, D C Des Jarlais, H Cohen, et al.
Science (New York, N.Y.)|November 11, 1988
A larger spectrum of severe HIV-1--related disease in intravenous drug users in New York CityR L Stoneburner, D C Des Jarlais, D Benezra, et al.
AIDS (London, England)|July 1, 1987
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug usersD C Des Jarlais, S R Friedman, M Marmor, et al.
American Journal of Public Health|March 8, 2000
HIV incidence among injection drug users in New York City, 1992-1997: evidence for a declining epidemicD C Des Jarlais, M Marmor, P Friedmann, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|January 7, 1998
"Why I am not infected with HIV": implications for long-term HIV risk reduction and HIV vaccine trialsD C Des Jarlais, S Vanichseni, M Marmor, et al.
American Journal of Public Health|February 24, 2001
Factors associated with prevalent hepatitis C: differences among young adult injection drug users in lower and upper Manhattan, New York CityT Diaz, D C Des Jarlais, D Vlahov, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 1, 1987
Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the diseaseS Zolla-Pazner, D C Des Jarlais, S R Friedman, et al.
Current HIV/AIDS Reports|June 23, 2018
Young Drug Users: a Vulnerable Population and an Underutilized Resource in HIV/HCV PreventionPedro Mateu-Gelabert, H Guarino, K Quinn, et al.
NIDA Research Monograph|January 1, 1986
A stage model of HTLV-III LAV infection in intravenous drug usersD C Des Jarlais, S R Friedman, T J Spira, et al.
Pageof 15